TMPRSS2 and prostate carcinoma: More than half of all prostate cancers carry this gene fusion which links the androgen-regulated TMPRSS2 gene with the transcription factor ERG [8, 43] resulting in an androgen-dependent overexpression of the ERG transcription factor [44].